$TRNS
TRANSCAT INC Stock $trns

$trns Overview Financials Valuation SEC Filings Company Website

2020 Q2 Form 10-Q Financial Statement

#000120677420002297 Filed on August 05, 2020

Income Statement

Concept	2020 Q2	2019 Q2
Revenue	$38.90M	$42.40M
YoY Change	-8.23%	15.64%
Cost Of Revenue	$29.50M	$32.34M
YoY Change	-8.81%	17.4%
Gross Profit	$9.409M	$10.05M
YoY Change	-6.4%	10.34%
Gross Profit Margin	24.19%	23.71%
Selling, General & Admin	$8.445M	$8.094M
YoY Change	4.34%	14.16%
% of Gross Profit	89.75%	80.52%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.872M	$1.622M
YoY Change	15.41%	3.31%
% of Gross Profit	19.9%	16.14%
Operating Expenses	$8.445M	$8.094M
YoY Change	4.34%	14.32%
Operating Profit	$964.0K	$1.958M
YoY Change	-50.77%	-3.55%
Interest Expense	-$220.0K	-$240.0K
YoY Change	-8.33%	14.29%
% of Operating Profit	-22.82%	-12.26%
Other Income/Expense, Net	-$243.0K	-$285.0K
YoY Change	-14.74%	1325.0%
Pretax Income	$721.0K	$1.673M
YoY Change	-56.9%	-7.06%
Income Tax	-$77.00K	-$45.00K
% Of Pretax Income	-10.68%	-2.69%
Net Earnings	$798.0K	$1.718M
YoY Change	-53.55%	20.14%
Net Earnings / Revenue	2.05%	4.05%
Basic Earnings Per Share	$0.11	$0.24
Diluted Earnings Per Share	$0.11	$0.23
COMMON SHARES
Basic Shares Outstanding	7.394M shares	7.257M shares
Diluted Shares Outstanding	7.514M shares	7.491M shares

Balance Sheet

Concept	2020 Q2	2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$400.0K	$600.0K
YoY Change	-33.33%	20.0%
Cash & Equivalents	$366.0K	$621.0K
Short-Term Investments
Other Short-Term Assets	$1.900M	$1.700M
YoY Change	11.76%	41.67%
Inventory	$14.19M	$15.90M
Prepaid Expenses
Receivables	$27.85M	$26.70M
Other Receivables	$894.0K	$1.400M
Total Short-Term Assets	$45.25M	$46.30M
YoY Change	-2.28%	21.84%
LONG-TERM ASSETS
Property, Plant & Equipment	$20.87M	$26.90M
YoY Change	-22.41%	51.98%
Goodwill	$41.68M
YoY Change
Intangibles	$7.349M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$733.0K	$700.0K
YoY Change	4.71%	-22.22%
Total Long-Term Assets	$78.92M	$67.40M
YoY Change	17.09%	19.29%
TOTAL ASSETS
Total Short-Term Assets	$45.25M	$46.30M
Total Long-Term Assets	$78.92M	$67.40M
Total Assets	$124.2M	$113.7M
YoY Change	9.2%	20.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$9.326M	$13.20M
YoY Change	-29.35%	7.32%
Accrued Expenses	$6.600M	$6.800M
YoY Change	-2.94%	78.95%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.003M	$1.900M
YoY Change	5.42%	-9.52%
Total Short-Term Liabilities	$17.92M	$22.00M
YoY Change	-18.56%	18.28%
LONG-TERM LIABILITIES
Long-Term Debt	$26.52M	$20.40M
YoY Change	30.02%	5.15%
Other Long-Term Liabilities	$2.682M	$8.000M
YoY Change	-66.48%	321.05%
Total Long-Term Liabilities	$29.21M	$28.40M
YoY Change	2.84%	33.33%
TOTAL LIABILITIES
Total Short-Term Liabilities	$17.92M	$22.00M
Total Long-Term Liabilities	$29.21M	$28.40M
Total Liabilities	$56.71M	$53.00M
YoY Change	6.99%	27.4%
SHAREHOLDERS EQUITY
Retained Earnings	$46.59M
YoY Change
Common Stock	$21.71M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$67.46M	$60.70M
YoY Change
Total Liabilities & Shareholders Equity	$124.2M	$113.7M
YoY Change	9.2%	20.32%

Cashflow Statement

Concept	2020 Q2	2019 Q2
OPERATING ACTIVITIES
Net Income	$798.0K	$1.718M
YoY Change	-53.55%	20.14%
Depreciation, Depletion And Amortization	$1.872M	$1.622M
YoY Change	15.41%	3.31%
Cash From Operating Activities	$4.042M	$874.0K
YoY Change	362.47%	-71.44%
INVESTING ACTIVITIES
Capital Expenditures	$1.261M	$1.446M
YoY Change	-12.79%	-175.31%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$180.0K
YoY Change	-100.0%
Cash From Investing Activities	-$1.261M	-$1.262M
YoY Change	-0.08%	-34.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$904.0K	$977.0K
YoY Change	-7.47%	-1321.25%
Debt Paid & Issued, Net	$487.0K	$467.0K
YoY Change	4.28%
Cash From Financing Activities	-$2.721M	$379.0K
YoY Change	-817.94%	-127.46%
NET CHANGE
Cash From Operating Activities	$4.042M	$874.0K
Cash From Investing Activities	-$1.261M	-$1.262M
Cash From Financing Activities	-$2.721M	$379.0K
Net Change In Cash	-$133.0K	-$167.0K
YoY Change	-20.36%	-30.42%
FREE CASH FLOW
Cash From Operating Activities	$4.042M	$874.0K
Capital Expenditures	$1.261M	$1.446M
Free Cash Flow	$2.781M	-$572.0K
YoY Change	-586.19%	-111.49%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q2	dei	Entity Central Index Key EntityCentralIndexKey	0000099302
CY2020Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-28
CY2020Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2020Q2	dei	Amendment Flag AmendmentFlag	false
CY2020Q2	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2020Q2	dei	Document Transition Report DocumentTransitionReport	false
CY2020Q2	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2020Q2	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q2	dei	Entity Shell Company EntityShellCompany	false
CY2020Q2	dei	Document Type DocumentType	10-Q
CY2020Q2	dei	Document Period End Date DocumentPeriodEndDate	2020-06-27
CY2020Q2	dei	Entity File Number EntityFileNumber	000-03905
CY2020Q2	dei	Entity Registrant Name EntityRegistrantName	TRANSCAT, INC.
CY2020Q2	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	OH
CY2020Q2	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	16-0874418
CY2020Q2	dei	Entity Address Address Line1 EntityAddressAddressLine1	35 Vantage Point Drive
CY2020Q2	dei	Entity Address City Or Town EntityAddressCityOrTown	Rochester
CY2020Q2	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2020Q2	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	14624
CY2020Q2	dei	City Area Code CityAreaCode	585
CY2020Q2	dei	Local Phone Number LocalPhoneNumber	352-7777
CY2020Q2	dei	Security12b Title Security12bTitle	Common Stock, $0.50 par value
CY2020Q2	dei	Trading Symbol TradingSymbol	TRNS
CY2020Q2	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2020Q2	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2020Q2	dei	Entity Small Business EntitySmallBusiness	true
CY2020Q2	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7413535	shares
CY2020Q2	us-gaap	Revenues Revenues	38904000	USD
CY2019Q2	us-gaap	Revenues Revenues	42395000	USD
CY2020Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	29495000	USD
CY2019Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	32343000	USD
CY2020Q2	us-gaap	Gross Profit GrossProfit	9409000	USD
CY2019Q2	us-gaap	Gross Profit GrossProfit	10052000	USD
CY2020Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4074000	USD
CY2019Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4472000	USD
CY2020Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4371000	USD
CY2019Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3622000	USD
CY2020Q2	us-gaap	Operating Expenses OperatingExpenses	8445000	USD
CY2019Q2	us-gaap	Operating Expenses OperatingExpenses	8094000	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	964000	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	1958000	USD
CY2020Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-243000	USD
CY2019Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-285000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	721000	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1673000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-77000	USD
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-45000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	798000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	1718000	USD
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.24
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7394000	shares
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7257000	shares
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.23
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7514000	shares
CY2019Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7491000	shares
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	798000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	1718000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	125000	USD
CY2020Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	26524000	USD
CY2020Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	28362000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	112000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	13000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	6000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	38000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	17000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	163000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	129000	USD
CY2020Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	961000	USD
CY2019Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1847000	USD
CY2020Q2	us-gaap	Cash Cash	366000	USD
CY2020Q1	us-gaap	Cash Cash	499000	USD
CY2020Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	730000	USD
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	480000	USD
CY2020Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	27849000	USD
CY2020Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	30952000	USD
CY2020Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	894000	USD
CY2020Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1132000	USD
CY2020Q2	us-gaap	Inventory Net InventoryNet	14194000	USD
CY2020Q1	us-gaap	Inventory Net InventoryNet	14180000	USD
CY2020Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1942000	USD
CY2020Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1697000	USD
CY2020Q2	us-gaap	Assets Current AssetsCurrent	45245000	USD
CY2020Q1	us-gaap	Assets Current AssetsCurrent	48460000	USD
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20871000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20833000	USD
CY2020Q2	us-gaap	Goodwill Goodwill	41681000	USD
CY2020Q1	us-gaap	Goodwill Goodwill	41540000	USD
CY2020Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7349000	USD
CY2020Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7977000	USD
CY2020Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8284000	USD
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8593000	USD
CY2020Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	733000	USD
CY2020Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	719000	USD
CY2020Q2	us-gaap	Assets Assets	124163000	USD
CY2020Q1	us-gaap	Assets Assets	128122000	USD
CY2020Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	9326000	USD
CY2020Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	11947000	USD
CY2020Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6588000	USD
CY2020Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6907000	USD
CY2020Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent		USD
CY2020Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	86000	USD
CY2020Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	2003000	USD
CY2020Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	1982000	USD
CY2020Q2	us-gaap	Liabilities Current LiabilitiesCurrent	17917000	USD
CY2020Q1	us-gaap	Liabilities Current LiabilitiesCurrent	20922000	USD
CY2020Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	3049000	USD
CY2020Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	3025000	USD
CY2020Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6535000	USD
CY2020Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6832000	USD
CY2020Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2682000	USD
CY2020Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1894000	USD
CY2020Q2	us-gaap	Liabilities Liabilities	56707000	USD
CY2020Q1	us-gaap	Liabilities Liabilities	61035000	USD
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.50
CY2020Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.50
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2020Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7411117	shares
CY2020Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7411117	shares
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7381180	shares
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7381180	shares
CY2020Q2	us-gaap	Common Stock Value CommonStockValue	3706000	USD
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	3691000	USD
CY2020Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	18006000	USD
CY2020Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	17929000	USD
CY2020Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-847000	USD
CY2020Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1010000	USD
CY2020Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	46591000	USD
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	46477000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	67456000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	67087000	USD
CY2020Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	124163000	USD
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	128122000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	798000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	1718000	USD
CY2020Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1000	USD
CY2019Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-238000	USD
CY2020Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	24000	USD
CY2019Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	12000	USD
CY2020Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1872000	USD
CY2019Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1622000	USD
CY2020Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	561000	USD
CY2019Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	102000	USD
CY2020Q2	us-gaap	Share Based Compensation ShareBasedCompensation	312000	USD
CY2019Q2	us-gaap	Share Based Compensation ShareBasedCompensation	203000	USD
CY2020Q2	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-2948000	USD
CY2019Q2	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-562000	USD
CY2020Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-5000	USD
CY2019Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1497000	USD
CY2020Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	251000	USD
CY2019Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	278000	USD
CY2020Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2621000	USD
CY2019Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1385000	USD
CY2020Q2	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	494000	USD
CY2019Q2	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-314000	USD
CY2020Q2	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-99000	USD
CY2019Q2	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-109000	USD
CY2020Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4042000	USD
CY2019Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	874000	USD
CY2020Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1261000	USD
CY2019Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1446000	USD
CY2020Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		USD
CY2019Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	184000	USD
CY2020Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1261000	USD
CY2019Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1262000	USD
CY2020Q2	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-1330000	USD
CY2019Q2	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	1823000	USD
CY2020Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	487000	USD
CY2019Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	467000	USD
CY2020Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	383000	USD
CY2019Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	369000	USD
CY2020Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1287000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	312000	USD
CY2020Q2	trns	Other Comprehensive Income Loss Net Of Taxes OtherComprehensiveIncomeLossNetOfTaxes	163000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	798000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	67456000	USD
CY2019Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1346000	USD
CY2020Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2721000	USD
CY2019Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	379000	USD
CY2020Q2	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-193000	USD
CY2019Q2	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-158000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-133000	USD
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-167000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	499000	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	788000	USD
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	366000	USD
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	621000	USD
CY2020Q2	us-gaap	Interest Paid Net InterestPaidNet	225000	USD
CY2019Q2	us-gaap	Interest Paid Net InterestPaidNet	245000	USD
CY2020Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	61000	USD
CY2019Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	57000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	59630000	USD
CY2019Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	369000	USD
CY2019Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1346000	USD
CY2019Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	203000	USD
CY2019Q2	trns	Other Comprehensive Income Loss Net Of Taxes OtherComprehensiveIncomeLossNetOfTaxes	129000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	1718000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	60703000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	67087000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	383000	USD
CY2020Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1287000	USD
CY2020Q1	us-gaap	Investments Investments	400000	USD
CY2019Q2	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-100000	USD
CY2020Q2	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-100000	USD
CY2019Q2	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-100000	USD
CY2020Q2	us-gaap	Derivative Asset Notional Amount DerivativeAssetNotionalAmount	4000000.0	USD
CY2020Q2	us-gaap	Investments Investments	400000	USD
CY2020Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	300000	USD
CY2019Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	200000	USD
CY2020Q2	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-100000	USD
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7514000	shares
CY2019Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7491000	shares
CY2020Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	20000	shares
CY2019Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	20000	shares
CY2020Q2	trns	Estimated Value Of Assets And Liabilities EstimatedValueOfAssetsAndLiabilities	8000000	USD
CY2020Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1700000	USD
CY2019Q2	trns	Dilutive Securities Effect Per Share On Earnings DilutiveSecuritiesEffectPerShareOnEarnings	-0.01
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7394000	shares
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7257000	shares
CY2020Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	120000	shares
CY2019Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	234000	shares
CY2020Q2	trns	Leverage Ratio Of Debt LeverageRatioOfDebt	1.50	pure
CY2019Q2	trns	Leverage Ratio Of Debt LeverageRatioOfDebt	1.53	pure
CY2020Q2	trns	Discrete Benefits Related To Sharebased Compensation Awards DiscreteBenefitsRelatedToSharebasedCompensationAwards	300000	USD
CY2019Q2	trns	Discrete Benefits Related To Sharebased Compensation Awards DiscreteBenefitsRelatedToSharebasedCompensationAwards	500000	USD
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	150000	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.63
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	5000	shares
CY2020Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	24.30
CY2020Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	25000	shares
CY2020Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	12.00
CY2020Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Other Increases Decreases In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod		shares
CY2020Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Other Share Increase Decrease In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	130000	shares
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	15.51
CY2020Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	980000	USD
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	90000	shares
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	12.25
CY2020Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	972000	USD
CY2020Q2	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	item
CY2020Q2	us-gaap	Revenues Revenues	38904000	USD
CY2019Q2	us-gaap	Revenues Revenues	42395000	USD
CY2020Q2	us-gaap	Gross Profit GrossProfit	9409000	USD
CY2019Q2	us-gaap	Gross Profit GrossProfit	10052000	USD
CY2020Q2	us-gaap	Operating Expenses OperatingExpenses	8445000	USD
CY2019Q2	us-gaap	Operating Expenses OperatingExpenses	8094000	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	964000	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	1958000	USD
CY2020Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-243000	USD
CY2019Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-285000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-77000	USD
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-45000	USD
CY2020Q2	us-gaap	Other General Expense OtherGeneralExpense	166000	USD
CY2019Q2	us-gaap	Other General Expense OtherGeneralExpense	240000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	798000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	1718000	USD
CY2019Q2	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	44420000	USD
CY2019Q2	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	1926000	USD
CY2019Q2	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	0.27
CY2019Q2	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	0.26

Files In Submission

Name	View Source	Status
0001206774-20-002297-index-headers.html	Edgar Link	pending
0001206774-20-002297-index.html	Edgar Link	pending
0001206774-20-002297.txt	Edgar Link	pending
0001206774-20-002297-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
transcat3788651-10q.htm	Edgar Link	pending
transcat3788651-10q_htm.xml	Edgar Link	completed
transcat3788651-ex101.htm	Edgar Link	pending
transcat3788651-ex311.htm	Edgar Link	pending
transcat3788651-ex312.htm	Edgar Link	pending
transcat3788651-ex321.htm	Edgar Link	pending
trns-20200627.xsd	Edgar Link	pending
trns-20200627_cal.xml	Edgar Link	unprocessable
trns-20200627_def.xml	Edgar Link	unprocessable
trns-20200627_lab.xml	Edgar Link	unprocessable
trns-20200627_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TRNS
TRANSCAT INC Stock $trns

2020 Q2 Form 10-Q Financial Statement

#000120677420002297 Filed on August 05, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TRNS TRANSCAT INC Stock $trns

2020 Q2 Form 10-Q Financial Statement

#000120677420002297 Filed on August 05, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TRNS
TRANSCAT INC Stock $trns